BFM 89.9
The Business Station
(16).png&w=3840&q=75&dpl=dpl_DcUQV83br1LXcSdJpCX1aY8d8epn)
Recommended
46 mins
45 mins
33 mins
Last week, Health Minister Khairy Jamaludin said that the government would procure 150,000 treatment packages of a Covid-19 anti-viral drug produced by Merck called Molnupiravir. The drug is being described by many quarters as a gamechanger in the fight against Covid-19. Based on trials conducted so far, the medication was shown to reduce the risk of hospitalization or death by around 50% in patients with mild-to-moderate symptoms of the virus. We get the lowdown on Molnupiravir from Sam Fazeli, Director of Research at Bloomberg Intelligence.
Image credit: Quality Stock Arts / Shutterstock.com
Presenter: Wong Shou Ning, Philip See, Shazana Mokhtar
Producer: Shazana Mokhtar
Share:
Recommended
Jul 3
·
46 minsWe Can Treat Obesity, But What About Stigma?
Jul 3
·
45 minsHow ‘Invisible People’ Gives Voice to the Forgotten
Recent episodes
0
Latest stories
Podcasts · Jul 3 · 8:00AM
We Can Treat Obesity, But What About Stigma?
46 mins
Podcasts · Jul 3 · 46 mins
We Can Treat Obesity, But What About Stigma?
Podcasts · Jul 3 · 7:00AM
How ‘Invisible People’ Gives Voice to the Forgotten
45 mins
Podcasts · Jul 3 · 45 mins
How ‘Invisible People’ Gives Voice to the Forgotten
Podcasts · Jul 3 · 4:00AM
Beyond Bitcoin: How Stablecoins Bridge Crypto & Real Money
33 mins
Podcasts · Jul 3 · 33 mins
Beyond Bitcoin: How Stablecoins Bridge Crypto & Real Money